Akopov A L, Rusanov A A, Chistiakov I V, Urtenova M A, Kazakov N V, Gerasin A V, Papaian G V
Vopr Onkol. 2013;59(6):740-4.
A prospective analysis of results of combined treatment of 22 patients with central stage II-III non-small cell lung cancer (NSCLC) was performed (the defeat of the main bronchi or lower parts of the trachea), which initially had been regarded as unresectable or inoperable (12 patients for functional reasons could not pass pneumonectomy, and in 10 patients a contraindication to primary surgery was the involvement of the distal trachea in tumor), but underwent surgery after preoperative treatment.Combination therapy included preoperative endobronchial photodynamic therapy (PDT) and chemotherapy followed by surgery and intraoperative PDT resection margins. PDT was carried out with the use of chlorine E6 (Radachlorin) and light wavelength of 662 nm. Overall response rate after neoadjuvant treatment was 82 %, endoscopic remission was observed in 21 of 22 patients (95%). 10 patients underwent pneumonectomy, 12--lobectomy. 19 surgical interventions were regarded as radical (R0--86%), 3--as microscopically non-radical (R1--14%). Degree of lymphatic metastasis spreading pN0 was detected in 6 patients (27 %), pN1--in 14 (64%) and pN2--in 2 patients (9%). Surgical lethality was 5%. In the late time of the whole observation period none of the patients developed local recurrence. One-year survival was 95%, 3-year--91%. PDT can play an important role in combination with surgical treatment for NSCLC and reduces the amount of resection in part of initially unresectable or inoperable patients.
对22例中心型II - III期非小细胞肺癌(NSCLC)患者(主支气管或气管下段受累)的联合治疗结果进行了前瞻性分析,这些患者最初被认为无法切除或不可手术(12例因功能原因无法进行肺切除术,10例因远端气管受肿瘤累及而存在一期手术禁忌),但在术前治疗后接受了手术。联合治疗包括术前支气管内光动力疗法(PDT)和化疗,随后进行手术及术中PDT切缘处理。PDT使用氯E6(拉达氯林)和662 nm的光波长进行。新辅助治疗后的总体缓解率为82%,22例患者中有21例(95%)观察到内镜缓解。10例患者接受了肺切除术,12例接受了肺叶切除术。19例手术被视为根治性手术(R0 - 86%),3例为显微镜下非根治性手术(R1 - 14%)。检测到6例患者(27%)有pN0级淋巴转移扩散,14例(64%)为pN1级,2例(9%)为pN2级。手术死亡率为5%。在整个观察期的后期,没有患者出现局部复发。1年生存率为95%,3年生存率为91%。PDT在NSCLC的联合手术治疗中可发挥重要作用,并可减少部分最初无法切除或不可手术患者的切除范围。